Keycare Drugs Private Limited, a active private limited company, was established on 30 October 2019 in Patancheru, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24299TG2019PTC136467. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹9.99 Cr and a paid-up capital of ₹9.99 Cr.
It upholds a compliant status. Its leadership includes Prakash Rao Janagama (Director), Bhavanam Raghunath Reddy (Director), Archana Thanniru (Director). Past directors included Sampath Rao Thanniru. It holds ₹7.50 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. M45, Medical Device Park,, Sultanpur,, Patancheru, Telangana, 502319.
U24299TG2019PTC136467
136467
30 October 2019
₹9.99 Cr
₹9.99 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Keycare Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prakash Rao Janagama | Director | 03 Oct 2020 | Current |
| Bhavanam Raghunath Reddy | Director | 03 Oct 2020 | Current |
| Archana Thanniru | Director | 30 Oct 2019 | Current |
| Akkineni Purnachandra Rao | Director | 03 Oct 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Oct 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Keycare Drugs Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 171.37% decrease in profit. The company's net worth Soared by an impressive increase of 1225.23%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Keycare Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹75,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Aug 2023 | United Bank Of India | ₹3.50 Cr | Open |
| 15 Apr 2023 | Others | ₹4.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Keycare Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Keycare Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Keycare Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Keycare Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Keycare Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
The activity A charge with United Bank Of India amounted to Rs. 3.50 Cr with Charge ID 100765418 was registered on 01 Aug 2023. was completed.
The activity A charge with Others amounted to Rs. 4.00 Cr with Charge ID 100705023 was registered on 15 Apr 2023. was completed.
Progress on Prakash Rao Janagama was appointed as a Director was appointed as a Director on 03 Oct 2020 & has been associated with this company since 5 years 2 months . was documented.
The activity Bhavanam Raghunath Reddy was appointed as a Director was appointed as a Director on 03 Oct 2020 & has been associated with this company since 5 years 2 months . was completed.
The CIN of Keycare Drugs Private Limited is U24299TG2019PTC136467.
Keycare Drugs Private Limited is headquartered at Plot No. M45, Medical Device Park,, Sultanpur,, Patancheru, Telangana, 502319.
Keycare Drugs Private Limited was incorporated on 30 October 2019.
The current directors of Keycare Drugs Private Limited are
The primary industry of Keycare Drugs Private Limited is Pharma.
Keycare Drugs Private Limited is unlisted.
The authorized capital of Keycare Drugs Private Limited is ₹9.99 Cr, and the paid-up capital is ₹9.99 Cr.
The compliance status of Keycare Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX